ArticleInternational journal of immunopathology and pharmacology

Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach.

Tawfik Khoury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.